{{Rsnum
|rsid=11128347
|Gene=PDZRN3
|Chromosome=3
|position=73570410
|Orientation=plus
|GMAF=0.1359
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;G)
|geno3=(G;G)
|Gene_s=PDZRN3
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;G)
| geno3=(G;G)
| CEU | 0.9 | 19.5 | 79.6
| HCB | 3.6 | 24.1 | 72.3
| JPT | 0.9 | 21.2 | 77.9
| YRI | 1.4 | 18.4 | 80.3
| ASW | 1.8 | 19.3 | 78.9
| CHB | 3.6 | 24.1 | 72.3
| CHD | 5.5 | 22.9 | 71.6
| GIH | 0.0 | 17.8 | 82.2
| LWK | 2.7 | 26.4 | 70.9
| MEX | 1.7 | 31.0 | 67.2
| MKK | 10.3 | 31.4 | 58.3
| TSI | 6.9 | 11.8 | 81.4
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=21546767
|Trait=None
|Title=Genome-wide association scan for survival on dialysis in african-americans with type 2 diabetes.
|RiskAllele=
|Pval=6E-7
|OR=1.8500
|ORtxt=[1.45-2.33]
|OA=1
}}

{{PMID Auto
|PMID=22664479
|Title=A genome-wide association study for irinotecan-related severe toxicities in patients with advanced non-small-cell lung cancer.
}}

{{on chip | Affy GenomeWide 6}}